Oseltamox

Play pronunciation

Generic name:

StvenueqDrug Class(analgesic)

Oral

What is oral oseltamox?

Oral oral oseltamox is a brand-name medication that contains the same active ingredient as Ciprofloxacin HCl. It works by inhibiting the enzyme that produces DNA gyrase. This enzyme is necessary and sufficient for the repair of DNA, and it is also responsible for cell division and cell death.

In addition to being used for this purpose, oral oseltamox is also sometimes used in the treatment of other infections such as acute bacterial sinusitis, community-acquired pneumonia, and other forms of respiratory infections.

Oral oseltamox is available as a generic prescription.

What are the indications for oral oseltamox?

Oral oseltamox is used to treat bacterial infections. It is also used to treat acute bacterial sinusitis and other sinus infections in adults. In children and adolescents, oral oseltamox is also used to prevent and treat sinusitis and pneumonia in children and adolescents.

Oral oseltamox is indicated for use in adults. It is also indicated for the treatment of community-acquired pneumonia, as well as for the treatment of pneumonia caused by bacteria.

The use of oral oseltamox in children and adolescents under 12 years of age may be contraindicated because of the risk of harm to the child or adolescent.

Oral oseltamox should not be used in the following situations:

• If a child is taking other medicines that may be affected by oral oseltamox, including other antibiotics or other medicines that affect the intestinal mucosa.
• If a child has been taking oral oseltamox for a long time or has liver or kidney problems.
• In patients with a known allergy to ciprofloxacin or other quinolones, the use of oral oseltamox should be avoided.
• In patients who are at high risk of hypersensitivity to ciprofloxacin or any other quinolone or fluoroquinolone antibacterials.
• In patients who have taken certain other medicines for a long time, the use of oral oseltamox should be avoided.

The following table shows the indications for the use of oral oseltamox in children and adolescents and the possible side effects.

Product description

Product name:Ciprofloxacin Dexamethasone

Company name:

DIN:03572596

Status:Marketed

Status date:2002-06-03

Active ingredient(s)	Strength
Ciprofloxacin (ciprofloxacin)	0.5mg

Resources

Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.

For consumers

Resource	Description
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections: Part I: Health Professional Information; Part II: Scientific Information; and Patient Medication Information
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

For health care professionals

Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

For researchers

After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

All resources

Uses of Ciprofloxacin

Ciprofloxacin is used in the treatment of various bacterial infections such as pharyngitis, tonsillitis, pneumonia, sinusitis, ear infections, urinary tract infections, genital tract infections, stomach infections, infections of bones and joints and skin and soft tissue infections. It can also be used in the management of patients with anthrax inhalation exposure.

Therapeutic Category

Ciprofloxacin: Fluoroquinolone antibiotics

How Ciprofloxacin works

Ciprofloxacinworks by blocking the actions of certain bacterial proteins (such as DNA gyrase, topoisomerase IV) which is essential for the bacteria to survive. As a result, it destroys the susceptible bacteria and prevent their further growth and multiplication within the body which helps in reducing the severity of the infection.

When to consult your doctor

Consult your doctor if you experience:

• impairment of vision, taste and smell and hearing, depression, memory impairment, severe fatigue and severe sleep disorders
• severe allergic reaction with symptoms such as tightness in the chest, feeling dizzy, feeling sick, faint, and experience dizziness while standing
• impairment of eyesight, taste, smelling, hearing
• pain and swelling of tendons (Ex. in your ankle, wrist, elbow, shoulder or knee), difficulty in walking
• rapid irregular heartbeat
• fits, neurological disease, psychosis, nerve pain, painful urination, presence of crystals in urine

ClinicalFirstApproved to the US FDA

• treat bacterial infections
• pharyngitis and tonsillitis
• pharyngitis and rhinitis
• pharyngitis and rhinitis in men
• nasal sinuses and nasal congestion
• nasal congestion, nausea, burning eyes, sense of taste, vomiting, bloody stools

• Fluoroquinolone antibiotics: Fungal infections such as trichomoniasis, psychelipoeia, Giardia infections and bacterial vaginosis
• amoxicillin and other related medications
• Linezolid
• Azithromycin
• Cipro

Fungal infectionsInTReal or ear infectionsCiprofloxacin can also be used in the treatment of certain bacterial infections such as but not limited to the Acute Skipping ThemaJaw infection.

A recent study published inJAMAfound that the incidence of severe skin and soft tissue infections was significantly higher in patients who received the antibiotics than those who were not. The authors of the study concluded that in patients who received ciprofloxacin, the risk of developing skin and soft tissue infection was significantly greater in those who received the antibiotic, whereas the risk of severe infection was higher in those who were not treated.

In the study, ciprofloxacin caused 1,879 skin and soft tissue infections, including 2,093 (4.4 percent) in patients who received antibiotics, compared to 2,879 (4.6 percent) in the patients who received no antibiotic.

Researchers found that the incidence of skin and soft tissue infection was significantly higher in patients who received ciprofloxacin compared to patients who received no antibiotic. The researchers also found that the incidence of severe skin and soft tissue infection was significantly higher in patients who received ciprofloxacin, whereas the incidence of severe skin and soft tissue infection was higher in patients who received no antibiotic.

The authors of the study also found that, in patients who received ciprofloxacin, the risk of skin and soft tissue infection was significantly higher in those who received the antibiotic, whereas the risk of severe infection was higher in patients who received no antibiotic.

A study published in theArchives of Internal Medicinereported inthat, in the study, the incidence of skin and soft tissue infection was significantly higher in patients who received the antibiotic, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was significantly higher.

The authors of the study also noted that, in the study, the risk of skin and soft tissue infection was significantly higher in patients who received ciprofloxacin, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was significantly higher.

The researchers of the study concluded that in patients who received ciprofloxacin, the risk of skin and soft tissue infection was significantly higher in those who received the antibiotic, whereas the risk of severe infection was higher in patients who received no antibiotic.

The researchers noted that, in the study, the risk of skin and soft tissue infection was significantly higher in patients who received the antibiotic, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was significantly higher.

The researchers also noted that, in patients who received ciprofloxacin, the risk of skin and soft tissue infection was significantly higher in those who received the antibiotic, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was significantly higher.

A study published infound that the incidence of skin and soft tissue infection was significantly higher in patients who received the antibiotic, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was higher in patients who received no antibiotic.

The researchers of the study also noted that, in the study, the risk of skin and soft tissue infection was significantly higher in patients who received the antibiotic, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was significantly higher.

The researchers of the study noted that, in the study, the risk of skin and soft tissue infection was significantly higher in patients who received the antibiotic, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was significantly higher.

The researchers of the study also noted that, in patients who received ciprofloxacin, the risk of skin and soft tissue infection was significantly higher in those who received the antibiotic, whereas in patients who received no antibiotic, the risk of skin and soft tissue infection was significantly higher.

Ophthalmic ciprofloxacin comes as a solution (liquid) to apply to the eyes. Ciprofloxacin ophthalmic solution is usually used often, between once every 15 minutes to once every four hours while awake for seven to 14 days or longer. Ciprofloxacin ophthalmic ointment is usually applied three times a day for two days and then twice a day for five days. Use ciprofloxacin ophthalmic at around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use ciprofloxacin ophthalmic exactly as directed. Do not use it more often than prescribed by your doctor.

You should expect your symptoms to improve during your treatment. Call your doctor if your symptoms do not go away or get worse, or if you develop other problems with your eyes during your treatment.

Use ophthalmic ciprofloxacin until you finish the prescription, even if you feel better. If you stop using ophthalmic ciprofloxacin too soon, your infection may not be completely cured and the bacteria may become resistant to antibiotics.

To instill the eye drops, follow these steps:

1. Wash your hands thoroughly with soap and water.

2. Check the dropper tip to make sure that it is not chipped or cracked.

3. Avoid touching the dropper tip against your eye or anything else; eyedrops and droppers must be kept clean.

4. While tilting your head back, pull down the lower lid of your eye with your index finger to form a pocket.

5. Hold the dropper (tip down) with the other hand, as close to the eye as possible without touching it.

6. Brace the remaining fingers of that hand against your face.

7. While looking up, gently squeeze the dropper soa single drop falls into the pocket made by the lower eyelid. Remove your index finger from the lower eyelid.

8. Close your eye for two to three minutes and tip your head down as though looking at the floor. Try not to blink or squeeze your eyelids.

9. Place a finger on the tear duct and apply gentle pressure.

10. Wipe any excess liquid from your face with a tissue.

11. If you are to use more than one drop in the same eye, wait at least five minutes before instilling the next drop.

12. Replace and tighten the cap on the dropper bottle. Do not wipe or rinse the dropper tip.

13. Wash your hands to remove any medication.

To apply the eye ointment, follow these instructions:

2. Avoid touching the tip of the tube against your eye or anything else; the tube tip must be kept clean.

3. Holding the tube between your thumb and forefinger, place it as near to your eyelid as possible without touching it.

5. Tilt your head backward slightly.

6. With your index finger, pull the lower eyelid down to form a pocket.

7. Squeeze a 1/2-inch (1.25cm) ribbon of ointment into the pocket made by the lower eyelid.

8. Blink your eye slowly; then gently close your eye for one to two minutes.

9. With a tissue, wipe any excess ointment from the eyelids and lashes. With another clean tissue, wipe the tip of the tube clean.

10. Replace and tighten the cap right away.

Ciprofloxacin (ciprofloxacin) can be used to treat a wide variety of bacterial infections.